During the past decade, Alabama Clinical Therapeutics, LLC conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 37 clinical trials were completed, i.e. on average, 94.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 21 clinical trials were completed. i.e. 161.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alabama Clinical Therapeutics, LLC" #1 sponsor was "Repros Therapeutics Inc." with 6 trials, followed by "Abbott Nutrition" with 5 trials sponsored, "Clarus Therapeutics, Inc." with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "AstraZeneca" with 5 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alabama Clinical Therapeutics, LLC" #1 collaborator was "Paidion Research, Inc." with 4 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Syneos Health" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Alabama Clinical Therapeutics, LLC" are "Male Hypogonadism" (5 trials), "Uterine Fibroids" (4 trials), "Degenerative Disc Disease" (3 trials), "Hypogonadism, Male" (3 trials) and "Secondary Hypogonadism" (3 trials). Many other conditions were trialed in "Alabama Clinical Therapeutics, LLC" in a lesser frequency.

Most popular intervention types in "Alabama Clinical Therapeutics, LLC" are "Drug" (60 trials), "Other" (14 trials), "Biological" (8 trials), "Device" (8 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Saline" (4 trials), "AC2993" (3 trials), "Oral testosterone undecanoate" (3 trials) and "AndroGel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Clinical Therapeutics, LLC" are 61 trials for "All" genders, 12 trials for "Male" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Alabama Clinical Therapeutics, LLC". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Alabama Clinical Therapeutics, LLC, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Clinical Therapeutics, LLC, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 16 trials that are defined as “Not Applicable".